The Medical Affairs Professional Society will take a deep look into how government regulations and commercial collaborations impact medical affairs in an upcoming webinar slated for noon EST Thursday, Aug. 30.
According to an email from MAPS, the online event will explore two instances that could potentially “open Medical Affairs up to censure.”
“Scenario one explores participation of commercial team members in Medical Advisory Boards and scenario two looks at the implications of a commercial team member requesting a medical team member to participate in a though leader meeting,” the email states.
Those who attend the webinar will be able to:
- Deep dive into regulatory and other guidance on medical/commercial collaborations;
- Explore latest updates to laws/regulations governing compliance;
- Learn best practices and key considerations when conducting Medical Advisory Boards; and
- Explore common compliance risks and approaches to mitigate risk and safeguard credibility in scientific exchange.
To find out more about this webinar, and how to register, click here.
